Effects of HM30181, a P-glycoprotein inhibitor, on the pharmacokinetics and pharmacodynamics of loperamide in healthy volunteers-Reference-Cited by-同舟云学术

Effects of HM30181, a P-glycoprotein inhibitor, on the pharmacokinetics and pharmacodynamics of loperamide in healthy volunteers

Published:2014-08-21 Issue:3 Volume:78 Page:556-564
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Kim Tae-Eun¹,Lee Howard²,Lim Kyoung Soo¹,Lee SeungHwan¹,Yoon Seo-Hyun¹^ORCID,Park Kyung-Mi³,Han Hyesun³,Shin Sang-Goo¹,Jang In-Jin¹,Yu Kyung-Sang¹,Cho Joo-Youn¹

Affiliation:

1. Department of Clinical Pharmacology and Therapeutics; Seoul National University College of Medicine and Hospital; Seoul Korea

2. Clinical Trials Center; Seoul National University Hospital; Seoul Korea

3. Clinical Research Team; Hanmi Pharm. Co., Ltd; Seoul Korea

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bcp.12368/fullpdf

Reference28 articles.

1. Placental transfer of antiretroviral drugs;Marzolini;Clin Pharmacol Ther,2005

2. P-glycoprotein inhibitors and their screening: a perspective from bioavailability enhancement;Varma;Pharmacol Res,2003

3. Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues;Thiebaut;Proc Natl Acad Sci U S A,1987

4. Recent advances in the research of P-glycoprotein inhibitors;Yang;Biosci Trends,2008

5. Overcoming multidrug resistance in cancer: an update on the clinical strategy of inhibiting P-glycoprotein;Thomas;Cancer Control,2003

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tetrazoles: A multi-potent motif in drug design;European Journal of Medicinal Chemistry;2024-09

2. Expression and Pharmaceutical Relevance of Intestinal Transporters;Oral Bioavailability and Drug Delivery;2023-10-10

3. Evaluation of Encequidar as An Intestinal P-gp and BCRP Specific Inhibitor to Assess the Role of Intestinal P-gp and BCRP in Drug-Drug Interactions;Pharmaceutical Research;2023-07-31

4. The Tetrahydroisoquinoline Scaffold in ABC Transporter Inhibitors that Act as Multidrug Resistance (MDR) Reversers;Current Topics in Medicinal Chemistry;2022-12

5. A dose regimen-finding study to evaluate the safety, tolerability, pharmacokinetics, and activity of oratecan in subjects with advanced malignancies;Cancer Chemotherapy and Pharmacology;2022-07-29